Ventrix initiates phase I trial of VentriGel in patients following myocardial infarction Sep. 18, 2015
Laguna opens phase III RESTORE SR trial of vanoxerine for atrial fibrillation and atrial flutter Sep. 15, 2015
FDA gives orphan drug status to udenafil for the treatment single ventricle congenital heart disease Sep. 8, 2015
RSS